Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease
Authors
Keywords
-
Journal
Frontiers in Cellular Neuroscience
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-09-26
DOI
10.3389/fncel.2014.00295
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dopamine D2 Receptor Relies upon PPM/PP2C Protein Phosphatases to Dephosphorylate Huntingtin Protein
- (2014) Sébastien Marion et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alterations in STriatal-Enriched protein tyrosine Phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington's disease mouse model
- (2014) Clare M. Gladding et al. JOURNAL OF NEUROCHEMISTRY
- The expanding universe of disorders of the basal ganglia
- (2014) Jose A Obeso et al. LANCET
- A restricted population of CB1 cannabinoid receptors with neuroprotective activity
- (2014) A. Chiarlone et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain
- (2013) G. Mazarei et al. EXPERIMENTAL NEUROLOGY
- A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin
- (2013) Maria Damiano et al. HUMAN MOLECULAR GENETICS
- Rhes, a Striatal-selective Protein Implicated in Huntington Disease, Binds Beclin-1 and Activates Autophagy
- (2013) Robert G. Mealer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of Huntington disease
- (2013) Gelareh Mazarei et al. JOURNAL OF NEUROCHEMISTRY
- Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
- (2013) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Early Down-Regulation of PKCδ as a Pro-Survival Mechanism in Huntington’s Disease
- (2013) Laura Rué et al. NEUROMOLECULAR MEDICINE
- Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: Implications for Huntington's disease
- (2013) Robert B. Laprairie et al. NEUROPHARMACOLOGY
- Attenuation of Rhes Activity Significantly Delays the Appearance of Behavioral Symptoms in a Mouse Model of Huntington's Disease
- (2013) Brandon A. Baiamonte et al. PLoS One
- Forkhead box protein p1 is a transcriptional repressor of immune signaling in the CNS: implications for transcriptional dysregulation in Huntington disease
- (2012) Bin Tang et al. HUMAN MOLECULAR GENETICS
- Activation of Elk-1 participates as a neuroprotective compensatory mechanism in models of Huntington’s disease
- (2012) Marta Anglada-Huguet et al. JOURNAL OF NEUROCHEMISTRY
- Abnormal response to cortical activation in early stages of Huntington disease
- (2012) Fanny Mochel et al. MOVEMENT DISORDERS
- Capucin does not modify the toxicity of a mutant Huntingtin fragment in vivo
- (2012) Laurie Galvan et al. NEUROBIOLOGY OF AGING
- Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter
- (2011) Elodie Martin et al. HUMAN MOLECULAR GENETICS
- Early Alterations of Brain Cellular Energy Homeostasis in Huntington Disease Models
- (2011) Fanny Mochel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- On the Existence of a Possible A2A–D2–β-Arrestin2 Complex: A2A Agonist Modulation of D2 Agonist-Induced β-Arrestin2 Recruitment
- (2011) Dasiel O. Borroto-Escuela et al. JOURNAL OF MOLECULAR BIOLOGY
- Differential Electrophysiological Changes in Striatal Output Neurons in Huntington's Disease
- (2011) V. M. Andre et al. JOURNAL OF NEUROSCIENCE
- Striatal-Enriched Protein Tyrosine Phosphatase Expression and Activity in Huntington's Disease: A STEP in the Resistance to Excitotoxicity
- (2011) A. Saavedra et al. JOURNAL OF NEUROSCIENCE
- Worsening of Huntington disease phenotype in CB1 receptor knockout mice
- (2011) Stéphane Mievis et al. NEUROBIOLOGY OF DISEASE
- What have we learned from gene expression profiles in Huntington's disease?
- (2011) Tamara Seredenina et al. NEUROBIOLOGY OF DISEASE
- Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function
- (2011) L.A. Raymond et al. NEUROSCIENCE
- The Physiology, Signaling, and Pharmacology of Dopamine Receptors
- (2011) J.-M. Beaulieu et al. PHARMACOLOGICAL REVIEWS
- Genome-Wide Identification of Bcl11b Gene Targets Reveals Role in Brain-Derived Neurotrophic Factor Signaling
- (2011) Bin Tang et al. PLoS One
- Decreased Striatal RGS2 Expression Is Neuroprotective in Huntington's Disease (HD) and Exemplifies a Compensatory Aspect of HD-Induced Gene Regulation
- (2011) Tamara Seredenina et al. PLoS One
- Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease
- (2010) Cristina Blázquez et al. BRAIN
- CalDAG-GEFI down-regulation in the striatum as a neuroprotective change in Huntington's disease
- (2010) Jill R. Crittenden et al. HUMAN MOLECULAR GENETICS
- The Clinical and Genetic Features of Huntington Disease
- (2010) Aaron Sturrock et al. JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
- A2A receptor knockout worsens survival and motor behaviour in a transgenic mouse model of Huntington's disease
- (2010) Stéphane Mievis et al. NEUROBIOLOGY OF DISEASE
- Inhibition of the Striatal Specific Phosphodiesterase PDE10A Ameliorates Striatal and Cortical Pathology in R6/2 Mouse Model of Huntington's Disease
- (2010) Carmela Giampà et al. PLoS One
- Neuronal calcium sensors and synaptic plasticity
- (2009) Mascia Amici et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Mitochondria in Huntington's disease
- (2009) Maria Damiano et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Pathophysiology of Huntingtonʼs disease: from huntingtin functions to potential treatments
- (2009) Emmanuel Roze et al. CURRENT OPINION IN NEUROLOGY
- Expression analysis of novel striatal-enriched genes in Huntington disease
- (2009) Gelareh Mazarei et al. HUMAN MOLECULAR GENETICS
- Regulator of Calcineurin (RCAN1-1L) Is Deficient in Huntington Disease and Protective against Mutant Huntingtin Toxicityin Vitro
- (2009) Gennady Ermak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Diminished hippocalcin expression in Huntington’s disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons
- (2009) Nikita Rudinskiy et al. JOURNAL OF NEUROCHEMISTRY
- Fine-tuning of GPCR activity by receptor-interacting proteins
- (2009) Stefanie L. Ritter et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease
- (2009) Claire-Marie Dhaenens et al. NEUROBIOLOGY OF DISEASE
- Normal Aging Modulates the Neurotoxicity of Mutant Huntingtin
- (2009) Elsa Diguet et al. PLoS One
- Dopamine D2 Receptor Stimulation Potentiates PolyQ-Huntingtin-Induced Mouse Striatal Neuron Dysfunctions via Rho/ROCK-II Activation
- (2009) Carole Deyts et al. PLoS One
- Rhes, a Striatal Specific Protein, Mediates Mutant-Huntingtin Cytotoxicity
- (2009) S. Subramaniam et al. SCIENCE
- Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease
- (2009) Jose R Pineda et al. Molecular Brain
- An Update on Adenosine A2A-Dopamine D2 Receptor Interactions: Implications for the Function of G Protein-Coupled Receptors
- (2008) S. Ferre et al. CURRENT PHARMACEUTICAL DESIGN
- Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons
- (2008) Carlos Cepeda et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Intratelencephalic corticostriatal neurons equally excite striatonigral and striatopallidal neurons and their discharge activity is selectively reduced in experimental parkinsonism
- (2008) Bérangère Ballion et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II
- (2008) Alexandra Benchoua et al. HUMAN MOLECULAR GENETICS
- Dopaminergic and Glutamatergic Signaling Crosstalk in Huntington's Disease Neurodegeneration: The Role of p25/Cyclin-Dependent Kinase 5
- (2008) P. Paoletti et al. JOURNAL OF NEUROSCIENCE
- Dichotomous Anatomical Properties of Adult Striatal Medium Spiny Neurons
- (2008) T. S. Gertler et al. JOURNAL OF NEUROSCIENCE
- Ctip2 Controls the Differentiation of Medium Spiny Neurons and the Establishment of the Cellular Architecture of the Striatum
- (2008) P. Arlotta et al. JOURNAL OF NEUROSCIENCE
- Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease
- (2008) Paula A. Desplats et al. NEUROBIOLOGY OF DISEASE
- Dopamine D1 receptor–mediated aggregation of N-terminal fragments of mutant huntingtin and cell death in a neuroblastoma cell line
- (2008) P. Robinson et al. NEUROSCIENCE
- Quantitative gene expression profiling of mouse brain regions reveals differential transcripts conserved in human and affected in disease models
- (2008) Camille Brochier et al. PHYSIOLOGICAL GENOMICS
- The Ubiquitin-Proteasome Pathway in Huntington's Disease
- (2008) Siddhartha Mitra et al. TheScientificWorldJOURNAL
- Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death
- (2007) Emmanuel Roze et al. FASEB JOURNAL
- Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo
- (2007) Delphine Charvin et al. NEUROBIOLOGY OF DISEASE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search